GENEVIEVE DAVIS: Open Payments
NPI 1174045520 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,492 in 86 payments from 14 companies in 2025. Trend: 2023 $1,376 · 2024 $1,703 · 2025 $1,492
Food & beverage: $1,407Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $417 |
| Janssen Biotech, Inc. | 15 | $323 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $137 |
| Madrigal Pharmaceuticals | 4 | $112 |
| GENZYME CORPORATION | 4 | $85 |
| Phathom Pharmaceuticals, Inc. | 1 | $74 |
| Ardelyx, Inc. | 3 | $72 |
| Gilead Sciences, Inc. | 3 | $70 |
| Aimmune Therapeutics, Inc. | 3 | $57 |
| Ipsen Biopharmaceuticals, Inc | 3 | $52 |
Products named: TREMFYA, RINVOQ, XIFAXAN, REZDIFFRA, MAVYRET, DUPIXENT, SKYRIZI, VOQUEZNA.
Industry payments across NM — which companies pay providers there.
